Dr. Krantz has been on the faculty of the Department of Psychiatry and Biobehavioral Sciences at UCLA for twenty years, and serves active roles as both a basic scientist and a clinical psychiatrist.
After completing an MD/PhD in the Medical Scientist Training Program at UCLA, he completed internship and residency in psychiatry at the University of California, Los Angeles. He is board certified in Psychiatry by the American Board of Psychiatry and Neurology. After completing residency, he was then awarded a Howard Hughes Postdoctoral Fellowship for Physicians to investigate the regulation of vesicular neurotransmitter transporters in Robert Edwards’ laboratory at UCSF. He returned to UCLA in 2000.
Dr. Krantz’s primary clinical interest is the treatment of depression and he is a member of the Division of Neuromodulation within the Psychiatry department. He is also an attending physician in the UCLA Mood Disorders Clinic. His laboratory uses the model genetic organism Drosophila to study how neurotransmitter transporters influence synaptic transmission and behavior. He is also using Drosophila as a tool to investigate the mechanism of action of drugs used to treat depression and to investigate the fundamental principles that govern aminergic signaling.
